Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Lin BioScience licenses CDC7 kinase inhibitor from Columbia Univ., Memorial Sloan Kettering

Executive Summary

Columbia University and Memorial Sloan Kettering Cancer Center granted Lin BioScience Inc. exclusive global rights to IP surrounding a novel CDC7 kinase inhibitor, which Lin will develop as LBS007 for solid and blood cancers.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • R&D and Marketing (Licensing)

Related Companies